A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory …
H Lavretsky, KT Laird, B Krause-Sorio… - The American Journal of …, 2020 - Elsevier
Objective Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …
complaints that increase risk for dementia. New treatment strategies targeting both …
Combined treatment with memantine/es‐citalopram for older depressed patients with cognitive impairment: a pilot study
GH Pelton, OL Harper, SP Roose… - … journal of geriatric …, 2016 - Wiley Online Library
Objective The objective of the study is to assess combined antidepressant and memantine
treatment in older patients presenting with depression and cognitive impairment. Methods …
treatment in older patients presenting with depression and cognitive impairment. Methods …
Escitalopram prevents relapse in older patients with major depressive disorder
Objective The present study investigated the efficacy and tolerability of escitalopram in the
prevention of relapse of major depressive disorder (MDD) in older patients who had …
prevention of relapse of major depressive disorder (MDD) in older patients who had …
Escitalopram in the treatment of depressed elderly patients
S Kasper, H de Swart, HF Andersen - The American journal of geriatric …, 2005 - Elsevier
Objective Management of depression in elderly patients presents a significant medical
challenge, and there is a need for further clinical trials. The authors examined the efficacy …
challenge, and there is a need for further clinical trials. The authors examined the efficacy …
Escitalopram in the acute treatment of depressed patients aged 60 years or older
A Bose, D Li, C Gandhi - The American Journal of Geriatric Psychiatry, 2008 - Elsevier
Objective The present study examined the efficacy and tolerability of acute escitalopram
treatment in depressed patients aged 60 years or older. Methods Patients aged≥ 60 years …
treatment in depressed patients aged 60 years or older. Methods Patients aged≥ 60 years …
Predicting 6‐week treatment response to escitalopram pharmacotherapy in late‐life major depressive disorder
R Saghafi, C Brown, MA Butters… - … Journal of Geriatric …, 2007 - Wiley Online Library
Objective Approximately half of older patients treated for major depressive disorder (MDD)
do not achieve symptomatic remission and functional recovery with first‐line …
do not achieve symptomatic remission and functional recovery with first‐line …
Escitalopram for comorbid depression and anxiety in elderly patients: a 12-week, open-label, flexible-dose, pilot trial
S Mohamed, K Osatuke, M Aslam, J Kasckow - The American Journal of …, 2006 - Elsevier
BACKGROUND:: Comorbid depression and anxiety may result in greater symptom severity
and poorer treatment response than either condition alone. Selective serotonin reuptake …
and poorer treatment response than either condition alone. Selective serotonin reuptake …
Escitalopram in the long-term treatment of major depressive disorder in elderly patients
S Kasper, OM Lemming, H de Swart - Neuropsychobiology, 2007 - karger.com
Aim: The primary aim was to investigate the long-term safety and tolerability of escitalopram
(10 or 20 mg/day) treatment of elderly patients suffering from major depressive disorder. The …
(10 or 20 mg/day) treatment of elderly patients suffering from major depressive disorder. The …
Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with …
CF Reynolds III, MA Dew, LM Martire… - … journal of geriatric …, 2010 - Wiley Online Library
Objective More than half of the older adults respond only partially to first‐line antidepressant
pharmacotherapy. Our objective was to test the hypothesis that a depression‐specific …
pharmacotherapy. Our objective was to test the hypothesis that a depression‐specific …
Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot …
GH Pelton, OL Harper, MH Tabert… - … Journal of Geriatric …, 2008 - Wiley Online Library
Objective To assess combined antidepressant and cognitive enhancer treatment in elderly
patients presenting with depression plus cognitive impairment. Methods Twenty‐three …
patients presenting with depression plus cognitive impairment. Methods Twenty‐three …